medigraphic.com

2018, Number 2

<< Back Next >>

Cuba y Salud 2018; 13 (2)

Epidemiological and microbiological characterization of urinary tract infections in the Teaching Orthopedic Hospital “Fructuoso Rodríguez”. Year 2015

González CY, Duquesne AA, Ruiz TM

Language: Spanish
References: 26
Page: 11-17
PDF size: 1228.98 Kb.


ABSTRACT

Introduction: urinary tract infection represents one of the most frequent non-epidemic bacterial infections diagnosed worldwide.
Objective: to determine the prevalence of urinary infections in the samples of hospitalized patients and those from the community, the most frequently isolated microorganisms and their pattern of resistance.
Method: an observational, descriptive and cross-sectional study was carried out in the Microbiology Laboratory of the Teaching Orthopedic Hospital “Fructuoso Rodríguez” in the period from January to December 2015.
Results: the sample consisted of 195 urocultures with positive isolations, (35.3%) of the universe. The sex most affected with urinary tract infection was the female, (36.4%), with positive results in hospitalized patients and those from the community (23.4%). The microorganisms isolated most frequently were Escherichia coli, Staphylococcus aureus, Pseudomonas sp., Klebsiella spp, and Acinetobacter spp. E. coli and S. aureus recorded the highest percentages of antimicrobial resistance to ciprofloxacin, nalidixic acid and cotrimoxazole.
Conclusions: the selection of the correct antibiotic should be based on epidemiological, microbiological and pharmacological criteria that allow its more rational use, therefore, it is especially important to have the necessary resources for the correct identification of the mechanisms of resistance of microorganisms.


REFERENCES

  1. Genao L, Buhr GT. Urinary tract infections in older adults residing in long-term care facilities. Ann Longterm Care. 2012; 20:33-8.

  2. Bautista H, Suárez ND, Támara AM, Rodríguez LA. Etiología y susceptibilidad bacteriana a los antimicrobianos en niños con infecciones urinarias. Rev Mex Ped. 2009; 76(2):70-4.

  3. Dwyer LL, Harris-Kojetin LD, Valverde RH, Frazier JM, Simon AE, Stone ND, et al. Infections in long-term care populations in the United States. J Am Geriatr Soc. 2013; 61:342-9.

  4. Domingo AD, Cacho J, Coira Nieto A, Lepe Jiménez JA. Diagnóstico microbiológico de las infecciones del tracto urinario. Recomendaciones de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. http://www.seimc.org/documentos/protocolos/microbiologia/. Consultado 02/09/16.

  5. Clinical Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing; 27th Informational Supplement 2017. CLSI document M100-S17.

  6. Tosif S, Baker A, Oakley E, Donath S, Babl FE. Contamination rates of different urine collection methods for the diagnosis of urinary tract infections in young children. J Pediatr Child Health. 2012; 48: 659-64.

  7. Seija V, Frantchez V, Pintos M, Bataglino MN, Torales M, Díaz A, et al. Etiología de la infección urinaria de adquisición comunitaria y perfil de susceptibilidad de Escherichia coli a los principales agentes antimicrobianos. Rev Med Urug. 2010 [acceso 10 Dic 2012]; 26:14-24. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S168803902010000400011&lng=en&nrm=iso

  8. Díaz L, Cabrera L, Fernández T, González O, Carrasco M, Bravo L. Etiología bacteriana de la infección urinaria y susceptibilidad antimicrobiana en cepas de Escherichia coli. Rev Cubana Pediatr. 2006 [acceso 11 Ene 2013]; 78 (3):42-45. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_ serial&

  9. Garrity GM, Bell JA, Lilburm TG. Taxonomic outline of the prokaryotes. En: Bergey’s Manual of Systematic Bacteriology. 2nd ed. New York. [acceso 10 Dic 2012]: [aprox. 14 p.]. Disponible en: http://dx.doi.org/10.1007/bergeysoutline200310.

  10. Marra AR, Camargo LFA, Pignatari ACC. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2563 cases from a prospective nationwide surveillance study. J Clin Microbiol. 2011;49: 1866-71.

  11. Rocha JL, Tuon FF, Johnson JR. Sex, drugs, bugs and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance. Braz J Infect Dis. 2012; 26: 115-21.

  12. Rummukainen M, Jakobsson A, Matsinen M, Järvenpää S, Nissinen A, Karppi P, et al. Reduction in inappropriate prevention of urinary tract infections in long-term care facilities. Am J Infect Control. 2012;40(8):711–4.

  13. Montini G. Urinary tract infections: to prophylaxis or not to prophylaxis. Pediatr Nephrol. 2009; 1605-9:16-20.

  14. Church JA, Fitzgerald F, Walker AS, Gibb DM, and Prendergast AJ: The expanding role of co-trimoxazole in developing countries. Lancet Infect Dis 2015; 15: pp. 327-339.

  15. Puñales I, Mongote A, Torres G. Etiología bacteriana de la infección urinaria en niños. Rev Cub Med Gen Integr. 2012 [acceso 2 Oct 2012]; 28(4):22-4. Disponible en: http://www.scielo.sld.cu

  16. Navarro F, Miró E, Mirelis B. Lectura interpretada del antibiograma de enterobacterias. Enferm Infecc Microbiol Clinic. 2010; 28(9):638-45.

  17. Somarriba L, Llanes R, Sánchez MJ. Cólera en Haití: lecciones aprendidas por la Brigada Médica Cubana. Havana: Editorial Científi co-Técnica; 2013. p. 1–255.

  18. Rodríguez-Baño J, Navarro MD, Retamar P, Picón E, Pascual A. ß-Lactam/ß- Lactam inhibitor combinations for the treatment of bacteriemia due to extended spectrum ß-Lactamase producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis. 2012; 54: 167-74.

  19. Caracciolo A, Bettinelli A, Bonato C, Isimbaldi C, Tagliabue A, Longoni L, et al. Antimicrobial resistance among Escherichia coli that cause child hood community-acquired urinary tract infections in Northern Italy. Italian J Pediatr. 2011; 37: 3 http://www.ijponline.net/content/37/1/3 (accedido el 5 de enero de 2013).

  20. Sánchez GU, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S outpatients from 2000-2010. Antimicrob Agents Chemother. 2012; 56: 2181-3.

  21. Burke L, Humphreys H, Fitzgerald-Hughes D. The revolving door between hospital and community: extended-spectrum beta-lactamaseproducing Escherichia coli in Dublin. J Hosp Infect. 2012;81(3):192–8.

  22. Silva F, Cifuentes M, Pinto ME. Resultados de la vigilancia de susceptibilidad antimicrobiana en Chile: Consolidando una red. Rev Chilena Infectol. 2011; 28 (1): 19-27.

  23. Jump RP, Olds DM, Seifi N, Kypriotakis G, Jury LA, Peron EP, et al. Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a lid on antibiotic use. Infect Control Hosp Epidemiol. 2012;33(12):1185–92.

  24. Daneman N, Gruneir A, Bronskill SE, Newman A, Fischer HD, Rochon PA, et al. Prolonged antibiotic treatment in long-term care: role of the prescriber. JAMA Intern Med. 2013;173(8):673–82.

  25. Leis JA, Rebick GW, Daneman N, Gold WL, Poutanen SM, Lo P, et al. Reducing antimicrobial therapy for asymptomatic bacteruiuria among noncatheterized inpatients: a proof-of-concept study. Clin Infect Dis. 2014; 58(7):980–3.

  26. Beetza R, Westenfelderb M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents. 2011; 38 (Suppl): 42-50.




2020     |     www.medigraphic.com